Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α

Rheumatology International

Volumn 29, Issue 10, 2009, Pages 1161-1168

  Yun, Hee Jin ^a   Lee, Eun Gyeong ^a   Lee, Sang Il ^b   Chae, Han Jung ^c   Yoo, Wan Hee ^a  

^a Jeonbuk National University Medical School and Hospital   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Adrenomedullin (AM); OPG; Osteoclastogenesis; RANKL; Rheumatoid arthritis (RA)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADRENOMEDULLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OSTEOCLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ACID PHOSPHATASE; ADRENOMEDULLIN; ARTHRITIS, RHEUMATOID; COCULTURE TECHNIQUES; FIBROBLASTS; HUMANS; INTERLEUKIN-1; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECOMBINANT PROTEINS; RNA, MESSENGER; SYNOVIAL MEMBRANE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68149154959     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0832-0     Document Type: Article

References (23)

1. Cawston TE (1995) Proteinase and connective tissue breakdown. In: Henderson B, Edwards JCW, Pettipher ER (eds) Mechanisms and models in rheumatoid arthritis. Academic Press, London
2. MK Han JS Kim BH Park 2003 NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis J Leukoc Biol 73 525 529
3. EM Gravallese Y Harada JT Wang AH Gorn TS Thornhill SR Goldring 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis Am J Pathol 152 943 951
4. HY Lee HS Jeon EK Song 2006 CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis Arthritis Rheum 54 1747 1758
5. YY Kong H Yoshida I Sarosi 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 315 323
6. SR Goldring 2002 Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol Suppl 65 44 48
7. E Romas MT Gillespie TJ Martin 2002 Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis Bone 30 340 346
8. T Matsushita N Matsui S Yoshiya H Fujioka M Kurosaka 2004 Production of adrenomedullin from synovial cells in rheumatoid arthritis patients Rheumatol Int 24 20 24
9. E Chosa H Hamada K Kitamura T Eto N Tajima 2003 Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis J Rheumatol 30 2553 2556
10. E Gonzalez-Rey A Chorny F O'Valle M Delgado 2007 Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells Am J Pathol 170 263 271
11. FC Arnett SM Edworthy DA Bloch 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324
12. G Mbalaviele R Nishimura A Myoi 1998 Cadherin-6 mediates the heterotypic interaction between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation J Cell Biol 141 1467 1476
13. Y Nanke S Kotake K Yonemoto S Saito T Tomatsu N Kamatani 2003 Adrenomedullin in synovial fluids from patients with rheumatoid arthritis inhibits interleukin 6 production from synoviocytes Ann Rheum Dis 62 82 83
14. Z Han DL Boyle L Chang 2001 c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J Clin Invest 108 73 81
15. AM Badger DE Griswold R Kapadia 2000 Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis Arthritis Rheum 43 175 183
16. M Nishikawa A Myoui T Tomita K Takahi A Nampei H Yoshikawa 2003 Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653 Arthritis Rheum 48 2670 2681
17. LM McLatchie NJ Fraser MJ Main 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 333 339
18. K Kobayashi N Takahashi E Jimi 2000 Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275 285
19. K Fuller C Murphy B Kirstein SW Fox TJ Chambers 2002 TNF potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL Endocrinology 143 1108 1118
20. B Uzan HK Ea JM Launay 2006 A critical role for adrenomedullin-calcitonin receptor-like receptor in regulating rheumatoid fibroblast-like synoviocyte apoptosis J Immunol 176 5548 5558
21. N Nagaya T Satoh T Nishikimi 2000 Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure Circulation 101 498 503
22. MC Genovese JM Kremer 2004 Treatment of rheumatoid arthritis with etanercept Rheum Dis Clin North Am 30 2 311 328
23. P Caramaschi D Biasi M Colombatti 2006 Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity Rheumatol Int 26 3 209 214